We devote our resources to building a sophisticated biotech company and becoming
a pioneer in the biopharmaceutical industry. Dr. Howard Doong, our Chief
Executive Officer, and Dr. Tsung-Shann Jiang, the founder and majority
shareholder of the Company, understand the challenges and opportunities of the
biotech industry and intend to provide therapeutic solutions to significant
unmet medical needs and to improve health and quality of human life by
developing innovative botanical drugs to treat central nervous system (“CNS”)
and oncology/ hematology diseases.

The Company develops its pipeline by carefully tracking new medical discoveries
or medical device technologies in research institutions in the Asia-Pacific
region. Pre-clinical, disease animal model and Phase I safety studies are
examined closely by the Company’s scientists and other specialists known to the
Company to identify drugs or medical devices that it believes demonstrate
efficacy and safety based on the Company’s internal qualifications. Once a drug
or medical device is shown to be a good candidate for further development and
ultimately commercialization, ABVC licenses the drug or medical device from the
original researchers and introduces the drug or medical device clinical trial
plan to highly respected principal investigators in the United States, Australia
and Taiwan. In almost all cases, ABVC has found that research institutions in
each of those countries are eager to work with the Company to move forward with
Phase II clinical trials.
Our principal executive office is located at 44370 Old Warm Springs Blvd.,
Fremont, CA 94538. Our telephone number at our principal executive office is
(510) 668-0881. Our corporate website is www.abvcbiopharma.com.


ABVC BIOPHARMA, INC.

We devote our resources to building a sophisticated biotech company and becoming a pioneer in the biopharmaceutical industry. Dr. Howard Doong, our Chief Executive Officer, and Dr. Tsung-Shann Jiang, the founder and majority shareholder of the Company, understand the challenges and opportunities of the biotech industry and intend to provide therapeutic solutions to significant unmet medical needs and to improve health and quality of human life by developing innovative botanical drugs to treat central nervous system (“CNS”) and oncology/ hematology diseases. 

Should you buy, sell, or hold ABVC BIOPHARMA, INC. (ABVC) ?

ABVC BIOPHARMA, INC. (ABVC) : Buy or Sell